deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03933813

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Sponsor: University of Wisconsin, Madison

Conditions Anemia Epithelial Ovarian Cancer Iron Deficiency Anemia
Interventions Iron Sucrose
Updated 14 times since 2019 Last updated: Jan 3, 2023 Started: Jul 29, 2019 Primary completion: Nov 22, 2021 Completion: Nov 22, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow accrual

Other terminated trials from University of Wisconsin, Madison

See all terminations from University of Wisconsin, Madison

Other Anemia trials with similar outcome

Browse all Anemia trials

This PHASE1/PHASE2 trial investigates Anemia and Epithelial Ovarian Cancer and is currently terminated or withdrawn. University of Wisconsin, Madison leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Apr 2020 · 3 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Feb 2023 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

    Status: Recruiting → Terminated

  4. Nov 2022 — Feb 2023 [monthly]

    Recruiting PHASE1_PHASE2

  5. Dec 2021 — Nov 2022 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 9 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Recruiting PHASE1_PHASE2

  2. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Suspended → Recruiting

  3. Apr 2020 — Jul 2020 [monthly]

    Suspended PHASE1_PHASE2

    Status: Recruiting → Suspended

  4. Jan 2020 — Apr 2020 [monthly]

    Recruiting PHASE1_PHASE2

  5. Dec 2019 — Jan 2020 [monthly]

    Recruiting PHASE1_PHASE2

  6. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE1_PHASE2

  7. Sep 2019 — Nov 2019 [monthly]

    Recruiting PHASE1_PHASE2

  8. Jul 2019 — Sep 2019 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Jun 2019 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Wisconsin, Madison
Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations